Rogelio Allanigue
Family Medicine · Union City, PANPI 1568490514
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 353 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,552 and has fallen 89.0% since, to $171 in 2023.
Across 353 payments — averaging $15.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$833
- Novo Nordisk$786
- GSK$695
- Boehringer Ingelheim$416
- AbbVie$387
- Lilly USA, LLC$378
- plus $2K from 16 others
What the payments were for
- Food & beverage$5,388100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 56 | $833 |
| Novo Nordisk | 43 | $786 |
| GSK | 50 | $695 |
| Boehringer Ingelheim | 30 | $416 |
| AbbVie(2 entities) | 30 | $387 |
| Lilly USA, LLC | 24 | $378 |
| Merck | 23 | $366 |
| AstraZeneca | 23 | $345 |
| E.r. Squibb & Sons, L.L.C. | 14 | $240 |
| Johnson & Johnson | 14 | $213 |
| Novartis | 16 | $190 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $148 |
| Bayer | 5 | $98 |
| Amgen | 5 | $80 |
| Astellas Pharma US Inc | 3 | $55 |
| Amarin Pharma, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $46 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $1 |
How this compares
$5,389 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxybutynin Chloride | 26 | $244 |
| Levothyroxine Sodium | 22 | $201 |
| Donepezil Hcl | 27 | $177 |
| Omeprazole | 12 | $170 |
| Metformin Hcl ErMetformin Hcl | 27 | $122 |
| Amlodipine Besylate | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Union City
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- Mary ZakutneyIrwin$393K
- H WilkinsSellersville$380K
- Deborah WittPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.